https://www.fortunebusinessinsights.com/blood-screening-market-102552
https://www.fortunebusinessinsights.com/blood-screening-market-102552
https://www.fortunebusinessinsights.com/blood-screening-market-102552
The global blood screening market was valued at USD 2.31 billion in 2018 and is anticipated to grow to
USD 6.63 billion by 2032, reflecting a compound annual growth rate (CAGR) of 7.9% over the forecast
period. In 2018, North America led the global market, accounting for 41.86% of the total share.
The blood screening market plays a crucial role in ensuring the safety and quality of blood used for
transfusions, organ transplants, and clinical testing. This market is driven by the growing prevalence of
infectious diseases, the rising demand for early disease detection, and the increasing emphasis on public
health safety. Advancements in diagnostic technologies, such as nucleic acid testing and immunoassays,
have enhanced the accuracy, speed, and efficiency of blood screening procedures. The blood screening
market spans various applications including infectious disease detection, cancer biomarkers, and genetic
disorder testing. As healthcare systems worldwide continue to strengthen their disease prevention and
control strategies, the blood screening market is expected to experience sustained growth, especially in
emerging economies with expanding diagnostic infrastructures.
Continue reading for more details: https://www.fortunebusinessinsights.com/blood-screening-market-
102552
Market Segmentation
•
In terms of product type, the Blood Screening Market includes assay kits, testing instruments, and
software solutions.
• By technique, the Blood Screening Market is segmented into ELISA, nucleic acid testing,
immunoassays, and point-of-care testing.
• Application-wise, the Blood Screening Market covers infectious diseases, cancer markers, genetic
screening, and transfusion-transmitted infections.
• Based on end-user, the Blood Screening Market serves hospitals, diagnostic laboratories, blood
banks, and research institutes.
• The Blood Screening Market is also segmented by technology adoption, ranging from conventional
manual systems to fully automated high-throughput platforms.
List Of Key Companies Profiled:
• Bio-Rad Laboratories, Inc.
• Grifols, S.A.
• F. Hoffmann-La Roche
• Ortho Clinical Diagnostics
• BD
• DiaSorin S.p.A.
• Thermo Fisher Scientific Inc.
• Abbott
• QUOTIENT
• Other Players
Market Growth
sales@fortunebusinessinsights.com
•
the blood screening market is witnessing strong growth driven by increased demand for early
detection of infectious diseases and conditions.
•
rising awareness about the importance of blood safety is significantly contributing to the expansion
of the blood screening market.
•
technological advancements in automated screening platforms and rapid testing kits are fueling
momentum in the blood screening market.
• growing adoption of blood screening in hospitals, blood banks, and diagnostics centers is propelling
growth in the blood screening market.
•
the blood screening market is also benefitting from expanded screening programs and public health
initiatives aimed at ensuring transfusion safety.
Restraining Factors
• High initial investment and operational costs for advanced blood screening systems may hamper
growth of the Blood Screening Market.
•
Limited reimbursement policies and budget constraints in developing regions can slow expansion of
the Blood Screening Market.
• Regulatory hurdles and complex approval procedures pose challenges to innovation within the
Blood Screening Market.
• Variability in quality control, test accuracy, and standardization issues can impact adoption rates in
the Blood Screening Market.
• Shortages of skilled personnel and the need for technical training may hinder widespread
implementation of the Blood Screening Market.
Regional Analysis
• North America leads the Blood Screening Market, supported by established healthcare
infrastructure and high disease surveillance.
• Europe holds a robust position in the Blood Screening Market, with strong regulatory frameworks
and routine screening protocols.
• The Asia-Pacific region is emerging as a key growth driver for the Blood Screening Market, fueled by
expanding blood bank networks and rising health awareness.
•
Latin America is showing steady uptake within the Blood Screening Market, backed by public health
campaigns and improved diagnostic capabilities.
• The Middle East & Africa are gradually increasing their share in the Blood Screening Market, with
investments in healthcare infrastructure and screening programs.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free)
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com